Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials S Meltzer-Brody, H Colquhoun, R Riesenberg, CN Epperson, ... The Lancet 392 (10152), 1058-1070, 2018 | 556 | 2018 |
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial S Kanes, H Colquhoun, H Gunduz-Bruce, S Raines, R Arnold, ... The Lancet 390 (10093), 480-489, 2017 | 438 | 2017 |
Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an international consortium KT Putnam, M Wilcox, E Robertson-Blackmore, K Sharkey, V Bergink, ... The Lancet Psychiatry 4 (6), 477-485, 2017 | 263 | 2017 |
Antidepressant use in pregnancy: a critical review focused on risks and controversies N Byatt, KM Deligiannidis, MP Freeman Acta Psychiatrica Scandinavica 127 (2), 94-114, 2013 | 224 | 2013 |
Effect of zuranolone vs placebo in postpartum depression: a randomized clinical trial KM Deligiannidis, S Meltzer-Brody, H Gunduz-Bruce, J Doherty, J Jonas, ... JAMA psychiatry 78 (9), 951-959, 2021 | 173 | 2021 |
Pharmacotherapy of postpartum depression: current approaches and novel drug development A Frieder, M Fersh, R Hainline, KM Deligiannidis CNS drugs 33, 265-282, 2019 | 167 | 2019 |
Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring KM Deligiannidis, N Byatt, MP Freeman Journal of clinical psychopharmacology 34 (2), 244-255, 2014 | 164 | 2014 |
Complementary and alternative medicine therapies for perinatal depression KM Deligiannidis, MP Freeman Best Practice & Research Clinical Obstetrics & Gynaecology 28 (1), 85-95, 2014 | 163 | 2014 |
GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study KM Deligiannidis, EM Sikoglu, SA Shaffer, B Frederick, AE Svenson, ... Journal of psychiatric research 47 (6), 816-828, 2013 | 160 | 2013 |
Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year AR Kroll‐Desrosiers, BC Nephew, JA Babb, Y Guilarte‐Walker, ... Depression and anxiety 34 (2), 137-146, 2017 | 127 | 2017 |
The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale A Di Florio, K Putnam, M Altemus, G Apter, V Bergink, J Bilszta, R Brock, ... Psychological medicine 47 (5), 787-799, 2017 | 117 | 2017 |
Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression KM Deligiannidis, AR Kroll-Desrosiers, S Mo, HP Nguyen, A Svenson, ... Psychoneuroendocrinology 70, 98-107, 2016 | 109 | 2016 |
Zuranolone for the treatment of postpartum depression KM Deligiannidis, S Meltzer-Brody, B Maximos, EQ Peeper, M Freeman, ... American Journal of Psychiatry 180 (9), 668-675, 2023 | 98 | 2023 |
Antidepressant Augmentation Using the N-Methyl-d-Aspartate Antagonist Memantine: A Randomized, Double-Blind, Placebo-Controlled Trial EG Smith, KM Deligiannidis, CM Ulbricht, CS Landolin, JK Patel, ... The Journal of clinical psychiatry 74 (10), 867, 2013 | 89 | 2013 |
Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic resonance imaging and … KM Deligiannidis, CL Fales, AR Kroll-Desrosiers, SA Shaffer, V Villamarin, ... Neuropsychopharmacology 44 (3), 546-554, 2019 | 85 | 2019 |
Complementary and alternative medicine for the treatment of depressive disorders in women KM Deligiannidis, MP Freeman Psychiatric Clinics 33 (2), 441-463, 2010 | 74 | 2010 |
Postpartum Depression: Action Towards Causes and Treatment (PACT) Consortium.(2017). Clinical phenotypes of perinatal depression and time of symptom onset: Analysis of data … KT Putnam, M Wilcox, E Robertson-Blackmore, K Sharkey, V Bergink, ... Lancet Psychiatry 4 (6), 477-485, 0 | 62 | |
The impact of pregnancy on the pharmacokinetics of antidepressants: a systematic critical review and meta-analysis G Schoretsanitis, O Spigset, JC Stingl, KM Deligiannidis, M Paulzen, ... Expert opinion on drug metabolism & toxicology 16 (5), 431-440, 2020 | 57 | 2020 |
Understanding peripartum depression through neuroimaging: a review of structural and functional connectivity and molecular imaging research C Duan, J Cosgrove, KM Deligiannidis Current psychiatry reports 19, 1-13, 2017 | 56 | 2017 |
Expression of inflammatory markers in women with perinatal depressive symptoms R Buglione-Corbett, KM Deligiannidis, K Leung, N Zhang, M Lee, ... Archives of women's mental health 21, 671-679, 2018 | 50 | 2018 |